Infant Formula Prebiotic Oligosaccharide Fermentation Rate
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional infant formulas lack the prebiotic oligosaccharides found in human milk, which are essential for promoting beneficial gut bacteria and a healthy short-chain fatty acid profile, leading to potential digestive issues and immune system development challenges in formula-fed infants.
Innovation Solution
A nutritional composition comprising a lipid or fat, a protein source, long chain polyunsaturated fatty acids like DHA, and a prebiotic composition with at least 20% of an oligosaccharide that has a slower fermentation rate than galacto-oligosaccharide, along with optional TGF-β, to mimic the benefits of human milk oligosaccharides and support gut health.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional infant formulas are used, then production cost and manufacturing simplicity are maintained, but the composition lacks prebiotic oligosaccharides needed for beneficial gut bacteria growth and healthy SCFA profile
Solution Approach 1:
The patent creates a composite nutritional composition that integrates multiple components (prebiotic oligosaccharides, probiotics, lipids, proteins, and carbohydrates) into a unified infant formula system. This composite approach allows the formulation to provide both the nutritional requirements and the prebiotic benefits of human milk while maintaining manufacturing feasibility through standardized ingredient combinations
2Reliability
If human milk oligosaccharides are added to formula, then beneficial gut bacteria population increases and SCFA profile improves, but manufacturing complexity and cost increase
Solution Approach 1:
The patent specifies precise parameter ranges for prebiotic oligosaccharide content (0.5-5 g/L) and probiotic content (10^6-10^9 CFU/mL) to optimize gut health benefits while maintaining manufacturing practicality. These parameter definitions allow manufacturers to achieve consistent results within defined specifications, balancing efficacy with production feasibility
3Object-affected harmful factors
If faster fermenting oligosaccharides like GOS are used, then prebiotic effect is strong, but excessive gas, bloating, and digestive discomfort occur
Solution Approach 1:
The patent employs a strategy of using multiple prebiotic oligosaccharide types (GOS, FOS, isomalto-oligosaccharides, and polydextrose) with different fermentation rates and locations in the gastrointestinal tract. This allows the formulation to provide prebiotic benefits at different sites (small intestine and colon) while reducing the likelihood of excessive gas production and digestive discomfort associated with any single fast-fermenting oligosaccharide
4Ease of operation
If multiple prebiotic oligosaccharide types are combined, then digestive tolerance improves and harmful effects are reduced, but formulation complexity increases
Solution Approach 1:
The patent creates a multi-functional prebiotic system where different oligosaccharide types serve multiple purposes: GOS and FOS provide primary prebiotic effects, isomalto-oligosaccharides contribute to digestive tolerance and gradual fermentation, and polydextrose adds bulk and moderate fermentation. This multi-functional approach allows the formulation to achieve comprehensive gut health benefits while managing complexity through synergistic ingredient interactions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition enhances the population of beneficial gut bacteria, improves digestion, and provides a SCFA profile similar to breast-fed infants, reducing pathogenic bacteria and promoting overall gastrointestinal health while being well-tolerated and minimizing gas, bloating, and diarrhea.
Implementation Method 1
a prebiotic composition having at least 20% of an oligosaccharide which has a fermentation rate which is demonstrably slower than that of galacto-oligosaccharide
Data Source
AI summary
A nutritional composition for improving the immunological function of a subject, including a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; and about 0.1 to about 1 mg/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide which has a fermentation rate which is demonstrably slower than that of galacto-oligosaccharide.